KPV vs Thymulin
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Lys-Pro-Val, Alpha-MSH fragment
KPV is a tiny tripeptide, just three amino acids (lysine, proline, valine), that forms the tail end of the natural hormone alpha-MSH. It is studied almost entirely as an anti-inflammatory agent, particularly for gut and skin inflammation. There are no registered human clinical trials proving its benefits in people; the evidence base is cell-culture and animal studies, so anything you read about it treating disease is preliminary.
Also: Facteur thymique serique, FTS
Thymulin is a tiny nine-amino-acid hormone made by the epithelial cells of the thymus, first described in the 1970s as facteur thymique serique (FTS). It only works when bound to one zinc atom, which makes it an oddly neat marker of zinc status. It plays a part in training T cells, and animal work suggests anti-inflammatory and pain-reducing effects. It is sold online for immune support and hair loss, but there are no modern human trials of giving it, and the hair claims rest on lab dishes and a sponsor-linked cosmetic study.
Key Comparison Insights
- Both peptides belong to the Immune category, suggesting similar primary applications.
Detailed Comparison
| Attribute | KPV | Thymulin |
|---|---|---|
| Category | Immune | Immune |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | What makes KPV interesting is how it gets into cells. Research suggests it hitches a ride on a nutrient transporter called PepT1, which is normally found in the small intestine but gets switched on in the colon during inflammation. Once inside the cell, KPV appears to interfere with NF-kB, a master switch that turns on inflammatory genes, which in lab studies reduces output of pro-inflammatory signals like TNF-alpha, IL-1beta, and IL-6. Unlike its parent hormone alpha-MSH, KPV does not seem to activate the classic melanocortin receptors, so its proposed action is described as largely receptor-independent. These mechanisms are supported by laboratory work but should be treated as a working model, not settled fact. | Thymulin (sequence Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) binds zinc in a 1:1 ratio, and only the zinc-bound form has biological activity. It promotes T cell differentiation inside and outside the thymus and influences T cell subsets and cytokine production. Its levels fall with age as the thymus shrinks, and fall with zinc deficiency. Researchers led by Goya and Reggiani have described a two-way link with the pituitary: thymulin seems to affect pituitary hormone release, and pituitary hormones affect thymulin secretion. In rodent models, thymulin and a synthetic analogue reduced inflammation and pain signalling, partly by dampening pro-inflammatory cytokines. How much of this applies to a peptide injected into a healthy adult is unknown. |
| Common Dosing | 200-500 mcg daily 1-2x daily | No established dose Unknown |
| Administration | Subcutaneous injection or oral (capsules) | Sold for subcutaneous injection or topical use; neither route has been tested in controlled human trials |
| Typical Duration | 4-8 weeks typical | Unknown; no human trials to guide duration |
| Best Time to Take | Morning or as directed | No evidence-based timing |
Possible Side Effects May vary by individual |
|
|
| Research Summary | The honest picture: KPV's reputation rests on animal and in vitro research, not human trials. A frequently cited study in Gastroenterology (Dalmasso and colleagues, 2008) showed PepT1-mediated uptake of KPV reduced intestinal inflammation, and oral KPV lessened chemically induced colitis (DSS and TNBS models) in mice while lowering pro-inflammatory cytokines. A later 2016 study in PMC reported KPV also reduced tumor number in a mouse model of colitis-associated cancer in a PepT1-dependent way. These are genuinely interesting, reproducible animal findings. But there are no published randomized controlled trials in humans for inflammatory bowel disease, eczema, or any of the conditions it is marketed for. Claims that it treats Crohn's, leaky gut, or mast cell activation in people are extrapolations from rodent data, not proven outcomes. | Most of what is solid here is basic physiology. Dardenne and Pleau (1994) reviewed the zinc dependence: no zinc, no activity. Prasad and colleagues (JCI, 1988) showed that serum thymulin activity dropped in people made mildly zinc deficient by diet and came back with zinc supplementation, alongside shifts in T cell ratios and IL-2, so thymulin is a useful readout of zinc status. Reviews by Reggiani, Goya and colleagues (2012-2014) summarize anti-inflammatory and analgesic effects in rodents and gene therapy work in athymic mice, but frame human use as a future goal. On hair: Meier and colleagues (J Invest Dermatol, 2012) found a low dose of thymulin increased hair shaft growth in organ-cultured human scalp follicles, a dish result rather than a clinical one. A 2013 cosmetic study of a thymus peptide serum and shampoo reported less hair shedding on pull tests, but it was tied to the product maker and not a controlled regrowth trial. There are no controlled trials of injected or topical thymulin for immunity, aging or hair in people, and no human safety data. If you have low zinc, fixing that is better proven than adding the peptide. |
Frequently Asked Questions: KPV vs Thymulin
What is the difference between KPV and Thymulin?
KPV is a immune peptide that kpv is a tiny tripeptide, just three amino acids (lysine, proline, valine), that forms the tail end of the natural hormone alpha-msh. it is studied almost entirely as an anti-inflammatory agent, particularly for gut and skin inflammation. there are no registered human clinical trials proving its benefits in people; the evidence base is cell-culture and animal studies, so anything you read about it treating disease is preliminary. Thymulin is a immune peptide that thymulin is a tiny nine-amino-acid hormone made by the epithelial cells of the thymus, first described in the 1970s as facteur thymique serique (fts). it only works when bound to one zinc atom, which makes it an oddly neat marker of zinc status. it plays a part in training t cells, and animal work suggests anti-inflammatory and pain-reducing effects. it is sold online for immune support and hair loss, but there are no modern human trials of giving it, and the hair claims rest on lab dishes and a sponsor-linked cosmetic study. The main differences lie in their mechanisms of action and clinical applications.
Which is better, KPV or Thymulin?
Neither is universally "better" - the choice depends on your specific goals. KPV is typically used for immune purposes, while Thymulin is used for immune. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can KPV and Thymulin be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using KPV and Thymulin together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.